Literature DB >> 3782609

Normalized noise energy as an acoustic measure to evaluate pathologic voice.

H Kasuya, S Ogawa, K Mashima, S Ebihara.   

Abstract

In order to evaluate noise components included in pathologic voice signals, a novel acoustic measure, normalized noise energy (NNE), is proposed and its effectiveness for the detection of laryngeal pathologies is investigated with 250 vowel samples spoken by 64 control (normal) subjects and 186 patients with various laryngeal diseases. The NNE is automatically computed from the voice signals using an adaptive comb filtering method performed in the frequency domain. Experiments with the voice samples show that the NNE is especially effective for detecting glottic cancer, recurrent nerve paralysis, and vocal cord nodules. Specifically, when glottic cancer is represented in terms of the T classification adopted by the UICC (Union Internationale Contre le Cancer), glottic T2-T4 cancer can be perfectly discriminated from normal samples, but 22.6% of patients with glottic T1 cancer are incorrectly classified as normal, with an error rate of 9.4% for normal subjects.

Entities:  

Mesh:

Year:  1986        PMID: 3782609     DOI: 10.1121/1.394384

Source DB:  PubMed          Journal:  J Acoust Soc Am        ISSN: 0001-4966            Impact factor:   1.840


  10 in total

1.  A method for turbulent noise estimation in voiced signals.

Authors:  P Mitev; S Hadjitodorov
Journal:  Med Biol Eng Comput       Date:  2000-11       Impact factor: 2.602

2.  Assessment of effectiveness of acoustic analysis of voice for monitoring the evolution of vocal nodules after vocal treatment.

Authors:  Wasim Elhendi Halawa; Antonio Rodríguez Fernández Freire; Irene Vázquez Muñoz; Sofía Santos Pérez
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-09-06       Impact factor: 2.503

3.  Acoustic analysis of voice using WPCVox: a comparative study with Multi Dimensional Voice Program.

Authors:  Juan Ignacio Godino-Llorente; Víctor Osma-Ruiz; Nicolás Sáenz-Lechón; Ignacio Cobeta-Marco; Ramón González-Herranz; Carlos Ramírez-Calvo
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-10-09       Impact factor: 2.503

4.  Acoustical recognition of laryngeal pathology using the fundamental frequency and the first three formants of vowels.

Authors:  E Perrin; C Berger-Vachon; I Kauffmann; L Collet
Journal:  Med Biol Eng Comput       Date:  1997-07       Impact factor: 2.602

Review 5.  Speech disorders in Parkinson's disease: early diagnostics and effects of medication and brain stimulation.

Authors:  L Brabenec; J Mekyska; Z Galaz; Irena Rektorova
Journal:  J Neural Transm (Vienna)       Date:  2017-01-18       Impact factor: 3.575

6.  Objective and subjective evaluation of larynx in smokers and nonsmokers: a comparative study.

Authors:  Hansa Banjara; Varsha Mungutwar; Digvijay Singh; Anuj Gupta
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2011-11-30

7.  Quantitative analysis of voice quality in early glottic laryngeal carcinomas treated with radiotherapy.

Authors:  A S Dagli; H F Mahieu; J M Festen
Journal:  Eur Arch Otorhinolaryngol       Date:  1997       Impact factor: 2.503

8.  Laryngeal High-Speed Videoendoscopy: Sensitivity of Objective Parameters towards Recording Frame Rate.

Authors:  Anne Schützenberger; Melda Kunduk; Michael Döllinger; Christoph Alexiou; Denis Dubrovskiy; Marion Semmler; Anja Seger; Christopher Bohr
Journal:  Biomed Res Int       Date:  2016-11-21       Impact factor: 3.411

9.  Machine learning based identification of relevant parameters for functional voice disorders derived from endoscopic high-speed recordings.

Authors:  Patrick Schlegel; Stefan Kniesburges; Stephan Dürr; Anne Schützenberger; Michael Döllinger
Journal:  Sci Rep       Date:  2020-06-29       Impact factor: 4.379

10.  Interdependencies between acoustic and high-speed videoendoscopy parameters.

Authors:  Patrick Schlegel; Andreas M Kist; Melda Kunduk; Stephan Dürr; Michael Döllinger; Anne Schützenberger
Journal:  PLoS One       Date:  2021-02-02       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.